IIRC approval time takes about 10 years minimum. Then you have 20 years to cash that cow out before the patent runs out.
IIRC approval time takes about 10 years minimum. Then you have 20 years to cash that cow out before the patent runs out.
Also. Most substantial patents are filed way before the approval of the drug. Rarely if ever has a drug had, for example, a composition of matter patent for 20 years after approval-- even with the extensions for regulatory delay that the USPTO allows. Not to say that Pharma don't extensively engage in product life-cycle management, sometimes very questionably extending exclusivity of products, and that is something that should be addressed.
> If investment costs/risk aren't limiting abundant new drugs, what is?
If we had lots of new drugs available for testing in the first place, they would still require the 6y minimum of trials, then a few years for approval. So FDA doesn't really sound like a good reason to single out.